Skip to main content
Download PDF

Overview: referrals for genetic evaluation from child psychiatrists

Child and Adolescent Psychiatry and Mental Health volume 10, Article number: 7 (2016) Cite this article

Abstract

A growing multitude of known genetic diagnoses can result in presentation to child psychiatry. For numerous reasons, it is important to identify a genetic etiology in child psychiatry patients when it is present. Genetic diagnoses can guide treatment and enable access to specialized clinics and appropriate screening measures. They can also allow for genetic counseling for the patient and family. A better understanding of etiology with a named diagnosis can itself be of great value to many patients and families; prognostic information can be empowering. Since patients with genetic conditions may present to psychiatric care in diverse ways, child psychiatrists must decide who to refer for genetic evaluation. Here we create a table to provide a framework of concerning/notable history and exam features that a practicing child psychiatrist may encounter that should prompt one to consider whether a larger, unifying genetic diagnosis is at hand. We hope this framework will facilitate referral of child psychiatry patients to genetics so that more patients can benefit from an appropriate diagnosis.

Background

A growing multitude of known genetic diagnoses can result in presentation to child psychiatry. The prevalence of genetic diagnoses among child psychiatry patients is best studied for autism, where 10–20 % of cases have a diagnosable genetic cause [e.g. Fragile X (FXS)] [1–6]. There is little information about the prevalence of genetic conditions in child psychiatry patients more generally. There are a large number of different genetic conditions that may lead to psychiatric presentation in a child. A December 2015 search of the Online Mendelian Inheritance in Man database (OMIM.org®), a catalog of genetic conditions, reveals 42 genetic etiologic associations for both psychiatric symptoms and autism. As genetic understanding continues to progress, the overlap with child psychiatry grows and it becomes increasingly important for child psychiatrists to recognize signs of a possible underlying genetic diagnoses [7].

In some instances, a genetic condition may have a typical psychiatric presentation and psychiatric symptoms may appear isolated. In such cases, presentation may be indistinguishable from that of a typical psychiatric patient whose disease is polygenic and multifactorial and genetic diagnosis is more difficult [8]. However, in many cases a genetic etiology may be suggested by features of history or physical exam. If child psychiatrists are aware of red flags signifying possible genetic condition, more patients can be appropriately diagnosed.

This article addresses two questions: Why is it important to diagnose genetic conditions in child psychiatry patients? What should prompt a child psychiatrist to request a genetic consult for a patient?

Main text

Benefits of diagnosing genetic conditions

Identifying a genetic etiology in child psychiatry patients has many benefits [9]. Diagnosis of specific genetic conditions can guide treatment and allow access to specialized healthcare. For example, depression may herald Wilson disease, which can be effectively treated with chelators [10]. In metabolic disorders with psychiatric symptoms, a diagnosis can allow for appropriate management to avoid metabolic decompensations, which worsen both psychiatric and somatic symptoms [8]. In children with FXS, hyperactivity responds particularly well to methylphenidate. Hyperactivity is more responsive to methylphenidate as part of FXS versus part of autism spectrum disorder or intellectual disability, or possibly even non-specific ADHD [3]. When diagnosed, these patients can be put directly on methylphenidate and avoid many medication trials, which carry associated risks. Furthermore, because psychiatric symptoms may arise years before more specific organic signs, certain treatments may be more effective at the ‘psychiatric stage’ before occurrence of irreversible lesions. This is particularly true for metabolic disorders [11]. Genetic diagnosis also enables access to specialized clinics with greater understanding of and experience with these complex presentations [12]. There are a growing number of condition-specific and neurogenetic clinics that may be very beneficial to patients. Because wait times to appointments can be challenging, other consultation strategies (e.g. telehealth) may be considered.

Additionally, some genetic conditions are associated with known medical complications and may require routine screening or further medical work-up. For example, a patient presenting with autism spectrum disorder and macrocephaly who is found to have a PTEN mutation can then be enrolled in a cancer screening protocol. Further, diagnosis can allow for appropriate genetic counseling for the patient and family [12, 13].

Finally, a better understanding of etiology with a named diagnosis may itself be of great value to many. Most individuals would rather know they have a serious disease than continue without a diagnosis [14]. Diagnosis allows for improved understanding, educational planning, and social support, and peer networking [15, 16]. Prognostic information can be empowering.

Indications for genetic consultation

It is not practical to conduct a genetic workup on all patients, so child psychiatrists must decide whom to refer for genetic evaluation [1]. Child psychiatrists are in an important position to diagnose genetic conditions, as they often see children for whom a diagnosis has been elusive, who have unusual presentations, or who have been difficult to treat.

Patients with genetic conditions may present to psychiatric care in diverse ways. Table 1 shows genetic conditions that may in rare cases account for typical child psychiatry presentations. Psychiatric symptoms may be apparently isolated, making genetic diagnosis difficult. However, often a careful history and physical provides hints to a genetic diagnosis.

Table 1 Genetic syndromes may in rare cases manifest in more general child psychiatry presentations
Full size table

Some unusual psychiatric presentations or behaviors may suggest a particular genetic etiology. Skin picking may occur in Prader-Willi syndrome [25] while severe disruptions of sleep and nail pulling suggest Smith-Magenis syndrome [26]. In many cases, non-psychiatric features of the history or exam will provide clues to genetic etiology.

The purpose of Table 2 is to present a framework of notable history and exam features that should prompt a child psychiatrist to consider whether there is a larger, unifying genetic diagnosis at hand. All of these features are recognized as markers in pediatric genetic practice, however here the goal is to isolate the flags most likely to present in a child psychiatry practice [27]. This table is just a starting point and should not be considered exhaustive.

Table 2 Red flags for a possible genetic diagnosis in child psychiatry patients
Full size table

If one or more of these red flags are present, a child psychiatrist should consider requesting a genetic consultation. Whenever possible, genetic tests should be ordered in conjunction with a genetic team. On a practical level, determining which genetic tests to order can be confusing and outside the usual practice of most child psychiatrists. Even more important, many child psychiatrists are not comfortable explaining the intricacies of genetic testing and lack the infrastructure to deal with ramifications of positive results [28]. Informed consent must include discussion of the risks of genetic testing, which include harms associated with resultant treatments and incidental findings that can be life changing or psychologically disruptive [29]. There may be particular cases in which a child psychiatrist has experience with or training relevant to a certain genetic test and feels comfortable ordering this test, so this remains an individual call. However, in most cases it is best to involve a genetic team and employ their associated infrastructure. It is our hope that this table will help child psychiatrists communicate with genetic teams by allowing them to pinpoint the red flags that led them to consider a genetic etiology.

Conclusions

It is important to identify a genetic etiology in child psychiatry patients when it is present, as it has implications for treatment and counseling. Patients with genetic conditions may have unusual psychiatric symptoms or other abnormal history and physical findings. Here we present a table of red flags that a practicing child psychiatrist may identify, which could indicate an underlying genetic diagnosis. We hope this table will inspire child psychiatrists to think about genetic possibilities in their patient populations and make referrals for genetic evaluation when appropriate. Future work will be needed to validate this table in practice. However, being aware of these the flags has immediate utility in the clinical practice of child psychiatrists. To highlight how simple practice changes may have a big impact for diagnosing conditions, we provide a short list of tips and resources for making a genetic diagnosis in child psychiatry (Table 3). We hope that this commentary will encourage child psychiatrists to think about their growing overlap with the field of genetics. Recognition of the importance of genetic diagnoses in child psychiatry patients may stimulate more research into the prevalence of genetic disease, effective methods of screening and diagnosis, and strategies for treatment and management for these patients.

Table 3 Short list of tips and resources for making genetic diagnoses in child psychiatry
Full size table

References

  1. 1.

    Schiff M, Benoist JF, Aissaoui S, Boespflug-Tanguy O, Mouren MC, de Baulny HO, Delorme R. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS One. 2011;6(7):e21932.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsater H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(4):484–91.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Roberts JE, Miranda M, Boccia M, Janes H, Tonnsen BL, Hatton DD. Treatment effects of stimulant medication in young boys with fragile X syndrome. J Neurodev Disord. 2011;3(3):175–84.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Cochran DM, Dvir Y, Frazier JA. “Autism-plus” spectrum disorders: intersection with psychosis and the schizophrenia spectrum. Child Adolesc Psychiatr Clin N Am. 2013;22(4):609–27.

    Article  PubMed  Google Scholar 

  5. 5.

    Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2014;86(5):749–64.

    Article  Google Scholar 

  6. 6.

    Shen J, Lincoln S, Miller DT. Advances in genetic discovery and implications for counseling of patients and families with autism spectrum disorders. Curr Genet Med Rep. 2014;2(3):124–34.

    Article  Google Scholar 

  7. 7.

    Hyman SE. The genetics of mental illness: implications for practice. Bull World Health Organ. 2000;78(4):455–63.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis. 2007;30(5):631–41.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    ACMG Board of Directors. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2015;17(6):505–7.

    Article  Google Scholar 

  10. 10.

    Zimbrean PC, Schilsky ML. The spectrum of psychiatric symptoms in Wilson’s disease: treatment and prognostic considerations. Am J Psychiatry. 2015;172(11):1068–72.

    Article  PubMed  Google Scholar 

  11. 11.

    Demily C, Sedel F. Psychiatric manifestations of treatable hereditary metabolic disorders in adults. Ann Gen Psychiatry. 2014;13:27.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Schaefer GB, Mendelsohn NJ, Professional Practice and Guidelines Committee: Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399–407.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005;42(4):318–21.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Gahl WA, Tifft CJ. The NIH undiagnosed diseases program: lessons learned. JAMA. 2011;305(18):1904–5.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Saul R. Medical genetics in pediatric practice. 1st ed. American Academy of Pediatrics; 2013.

  16. 16.

    Reiff M, Giarelli E, Bernhardt BA, Easley E, Spinner NB, Sankar PL, Mulchandani S. Parents’ perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders. J Autism Dev Disord. 2015;45(10):3262–75.

    Article  PubMed  Google Scholar 

  17. 17.

    Stephenson DD, Beaton EA, Weems CF, Angkustsiri K, Simon TJ. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications. Behav Brain Res. 2015;276:190–8.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Saldarriaga W, Tassone F, Gonzalez-Teshima LY, Forero-Forero JV, Ayala-Zapata S, Hagerman R. Fragile X syndrome. Colomb Med (Cali). 2014;45(4):190–8.

    Google Scholar 

  19. 19.

    Ng R, Fillet P, DeWitt M, Heyman GD, Bellugi U. Reasoning about trust among individuals with Williams syndrome. Am J Intellect Dev Disabil. 2015;120(6):527–41.

    Article  PubMed  Google Scholar 

  20. 20.

    Ramos-Rios R, Berdullas J, Arauxo A, Santos-Garcia D. Schizophreniform psychosis at onset of adrenoleukodystrophy. CNS Spectr. 2009;14(12):711–2.

    PubMed  Google Scholar 

  21. 21.

    Bonnot O, Herrera PM, Tordjman S, Walterfang M. Secondary psychosis induced by metabolic disorders. Front Neurosci. 2015;9:177.

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Bortolato M, Shih JC. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol. 2011;100:13–42.

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Russell HF, Wallis D, Mazzocco MM, Moshang T, Zackai E, Zinn AR, Ross JL, Muenke M. Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. J Pediatr Psychol. 2006;31(9):945–55.

    Article  PubMed  Google Scholar 

  24. 24.

    Alam ST, Rahman MM, Islam KA, Ferdouse Z. Neurologic manifestations, diagnosis and management of Wilson’s disease in children—an update. Mymensingh Med J. 2014;23(1):195–203.

    CAS  PubMed  Google Scholar 

  25. 25.

    Rice LJ, Einfeld SL. Cognitive and behavioural aspects of Prader-Willi syndrome. Curr Opin Psychiatry. 2015;28(2):102–6.

    PubMed  Google Scholar 

  26. 26.

    Finucane B, Dirrigl KH, Simon EW. Characterization of self-injurious behaviors in children and adults with Smith-Magenis syndrome. Am J Ment Retard. 2001;106(1):52–8.

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    Pletcher BA, Toriello HV, Noblin SJ, Seaver LH, Driscoll DA, Bennett RL, Gross SJ. Indications for genetic referral: a guide for healthcare providers. Genet Med. 2007;9(6):385–9.

    Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Cohen J, Hoon A, Wilms Floet AM. Providing family guidance in rapidly shifting sand: informed consent for genetic testing. Dev Med Child Neurol. 2013;55(8):766–8.

    PubMed  Google Scholar 

  29. 29.

    Ross LF, Saal HM, David KL, Anderson RR, American Academy of Pediatrics, American College of Medical Genetics and Genomic: Technical report: Ethical and policy issues in genetic testing and screening of children. Genet Med. 2013;15(3):234–45.

    Article  PubMed  Google Scholar 

Download references

Authors’ contributions

All authors have substantially contributed to the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Author information

Affiliations

  1. 733 North Broadway, Suite 137-Office of Student Affairs, Edward D. Miller Research Building, Baltimore, MD, 21205, USA

    Katharine R. Press

  2. Bloomberg Children’s Center, 12th Floor, Room 12316, 1800 Orleans Street, Baltimore, MD, 21287, USA

    Laura Wieczorek

  3. Blalock 1008 Medical Genetics, 600 North Wolfe Street, Baltimore, MD, 21287, USA

    Julie Hoover-Fong & Joann Bodurtha

  4. Bloomberg Children’s Center, 12th Floor, Room 12352, 1800 Orleans Street, Baltimore, MD, 21287, USA

    Lynn Taylor

Authors
  1. Katharine R. Press
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Wieczorek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julie Hoover-Fong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joann Bodurtha
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lynn Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katharine R. Press.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Press, K.R., Wieczorek, L., Hoover-Fong, J. et al. Overview: referrals for genetic evaluation from child psychiatrists. Child Adolesc Psychiatry Ment Health 10, 7 (2016). https://doi.org/10.1186/s13034-016-0095-6

Download citation

Keywords

  • Diagnosis
  • Genetics
  • Child psychiatry

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000